Intravenous Procainamide for Predicting the Response of Sustained Ventricular Tachycardia to Type IIi Antiarrhythmic Drugs
Cohen
Journal of Invasive Cardiology 9(1): 45
1997
ISSN/ISBN: 1557-2501 PMID: 10762874 Document Number: 470040
Document emailed within 1 workday
Related Documents
Brembilla-Perrot, B.; Terrier de la Chaise, A.; Skeik, L.; Cherrier, F.; Pernot, C. 1987: Factors predicting the response to an antiarrhythmic during an electrophysiologic study for ventricular tachycardia Archives des Maladies du Coeur et des Vaisseaux 80(10): 1497-1503Epstein, L.M.; Scheinman, M.M. 1990: Should asymptomatic patients with coronary artery disease and nonsustained ventricular tachycardia be treated with antiarrhythmic drugs? Cardiovascular Clinics 21(1): 79
Steinbeck, G. 1992: Which patient with sustained ventricular tachycardia is suited for long-term therapy with anti-arrhythmia drugs? Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 47(5): 195-201
DiPersio, D.M.; Chow, M.S. 1985: Predicting plasma procainamide concentrations resulting from a sustained-release preparation Clinical Pharmacy 4(2): 186-191
Raviele, A.; Di Pede, F.; Piccolo, E. 1985: Protocol of the serial electropharmacological study for selecting the most efficacious chronic anti-arrhythmia therapy in patients with sustained recurrent ventricular tachycardia and in survivors of cardiac arrest secondary to ventricular tachycardia Giornale Italiano di Cardiologia 15(3): 354-357
Pirovino, M.; Karlaganis, G.; Galeazzi, R.L. 1980: Steady-state plasma and saliva concentrations of procainamide and N-acetyl-procainamide after a sustained release preparation Schweizerische Medizinische Wochenschrift 110(39): 1415-1419
Chen, R.J.; Ko, W-Je.; Lin, F-Yue. 2002: Successful rescue of sustained ventricular tachycardia/ventricular fibrillation after coronary artery bypass grafting by extracorporeal membrane oxygenation Journal of the Formosan Medical Association 101(4): 283-286
Orszulak-Michalak, D. 1995: The influence of selected general anesthetics on pharmacokinetic parameters of some antiarrhythmic drugs in rabbits. Part I. Procainamide and its active metabolite-N-acetylprocainamide Acta Poloniae Pharmaceutica 52(2): 141-146
Gupta, B.S.; Saigal, R.; Vottery, R.; Singhal, N.; Banerjee, S. 1999: Sustained ventricular tachycardia in a case of aconite poisoning Journal of the Association of Physicians of India 47(4): 455
Lukl, J.; Cíhalík, C.; Heinc, P. 1992: Serial testing of antiarrhythmic agents using programmed stimulation in recurrent ventricular tachycardia Vnitrni Lekarstvi 38(3): 246-251
Martínez-Larrañaga, M.R.; Anadón, A.; Sanz, F. 1977: Comparative study of the effects on the antiarrhythmic drugs procainamide, quinidine, diphenylhidantoin and spirohidantoin compounds derived from the nor-tropane system on the potentials of membrane and transport of sodium through the frog skin Archivos de Farmacologia y Toxicologia 3(3): 247-258
Zenker, M.A. 1995: Sustained monomorphic ventricular tachycardia: a case of cardiac sarcoidosis Journal of the Tennessee Medical Association 88(11): 435-436
Naccarella, F.; Mantovani, B.; Lamberti, C.; Boschi, S.; Bracchetti, D.; Magnani, B. 1979: Computerized analysis of the clinical effectiveness of intravenous/disopyramide and procainamide in patients with stabilized and complicated ventricular extrasystole Bollettino Della Societa Italiana di Cardiologia 24(12): 1297-1305
Vergara, G.; Inama, G.; Guarnerio, M.; Rando, F.; Oldani, V.; Furlanello, F. 1990: Electropharmacological test with pentisomide (CM 7857) in patients with sustained ventricular tachycardia Giornale Italiano di Cardiologia 20(6): 543-548
Aouate, P.; Frank, R.; Fontaine, G.; Fillette, F.; Rougier, I.; Grosgogeat, Y. 1990: Electrophysiology in evaluating the treatment of sustained monomorphic ventricular tachycardia: criteria for efficacy Archives des Maladies du Coeur et des Vaisseaux 83(2): 167-173
Orczykowski, Mł.; Szumowski, L.; Szufladowicz, E.; Bodalski, R.; Zakrzewska-Koperska, J.; Walczak, F. 2008: Sotalol prevents atrio-ventricular tachycardia but not atrial fibrillation with rapid ventricular response in a patient wiht WPW syndrome Kardiologia Polska 66(7): 800-804
Niwano, S.; Aizawa, Y.; Ebe, K.; Miyajima, S.; Funazaki, T.; Suzuki, K.; Satoh, M.; Shibata, A. 1988: Evaluation of therapeutic interventions of sustained monomorphic ventricular tachycardia guided by an electrophysiologic study: a case report Journal of Cardiology 18(4): 1155-1162
Naccarella, F.; Palmieri, M.; Nanni, G.; Barbato, G.; Casella, G.; Bartoletti, A.; Bracchetti, D. 1987: Sustained ventricular tachycardia: epidemiological, clinical and prognostic aspects. Long-term follow up of different subgroups of patients under anti-arrhythmia therapy. i Cardiologia 32(1): 55-64
Fiala, M.; Chovanzík, J.; Neuwirth, R.; Nykl, I.; Szymeczek, H.; Nevralová, R.; Jiravský, O.; Branny, M. 2006: Sustained monomorphic ventricular tachycardia in patients with structural heart disease. Different arrhythmogenic substrates, different options of palliative and curative treatment in the era of three-dimensional mapping Vnitrni Lekarstvi 52(6): 577-589
Naccarella, F.; Palmieri, M.; Barbato, G.; De Castro, U.; Bartoletti, A.; Guaragna, R.F.; Lombardi, G.; Bracchetti, D.; Turba, E.; Abbati, A. 1987: Long-term prognosis of chronic recurrent sustained ventricular tachycardia. Critical analysis of a prospective operative scheme followed since 1979 on 64 consecutive subjects. Ii Cardiologia 32(3): 315-327